Privia Health (PRVA) appointed Lance Berberian to its Board of Directors, effective July 15. He has also been named a member of the Audit Committee of the Board. Following the appointment of Berberian, the Board will comprise 10 directors. Berberian served as EVP and Chief Information and Technology Officer at Labcorp Holdings from 2014 to October 2024. Prior to Labcorp, Berberian held CIO roles at IDEXX Laboratories, Kellstrom Aerospace, Interim HealthCare and Quest Diagnostics.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRVA:
- Privia Health price target raised to $32 from $29 at JPMorgan
- Privia Health price target raised to $24 from $23 at Barclays
- Privia Health Group Approves Key Proposals at Meeting
- Privia Health’s Earnings Call Highlights Growth and Challenges
- Privia Health Group’s Strong Performance and Strategic Expansion Drive Positive Outlook